Evidence map›Paper›PMID 27447841›Full record

ArticleAddiction (Abingdon, England)2017

Effects of sex and alcohol use on antiretroviral therapy outcomes in Botswana: a cohort study.

Robert Gross, Scarlett L Bellamy, Bakgaki Ratshaa, Xiaoyan Han, Andrew P Steenhoff, Mosepele Mosepele, Gregory P Bisson

Open access · greenAbstract read
In one paragraph

Article in Addiction (Abingdon, England), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Robert GrossDepartment of Medicine (ID), University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.ORCID 0000-0001-6066-1159
Scarlett L BellamyDepartment of Biostatistics and Epidemiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Bakgaki RatshaaBotswana-University of Pennsylvania Partnership, Gaborone, Botswana.
Xiaoyan HanDepartment of Biostatistics and Epidemiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Andrew P SteenhoffBotswana-University of Pennsylvania Partnership, Gaborone, Botswana.
Mosepele MosepeleDepartment of Medicine, Faculty of Medicine, University of Botswana, Gaborone, Botswana.
Gregory P BissonDepartment of Medicine (ID), University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
University of Botswana · BWUniversity of Pennsylvania · USChildren's Hospital of Philadelphia · USUnited States Department of Veterans Affairs · US

Funding

Penn Mental Health AIDS Research CenterP30MH097488 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI Knashawn Hodge Morales · 2013 to 2026
$23.5M
Pharmacogenetics and HIV treatment outcomesR01MH080701 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI GROSS, ROBERT · 2009 to 2013
$2.6M
NIMH NIH HHS P30 MH097488NIMH NIH HHS R01 MH080701
6 · The paper itself

Abstract

aimsTo determine alcohol use effect on HIV treatment success and whether alcohol use mediates the relation between male sex and treatment failure.

designLongitudinal cohort study.

settingEight HIV clinics in and near Gaborone, Botswana.

participantsA total of 938 HIV-infected treatment-naive adults initiating regimens containing the antiretroviral medication efavirenz between June 2009 and February 2013, including 478 (51%) males, median age 38 years, and plasma HIV RNA 4.9 log MEASUREMENTS: Primary outcome was a composite of treatment failure over 6 months including death, lost to care or plasma HIV RNA > 25 copies/ml. Exposures included alcohol use and gender.

findingsFailure in 339 (36%) participants included 40 (4%) deaths, 194 (21%) lost to care and 105 (11%) with HIV RNA > 25 copies/ml. Both hazardous alcohol use in the past year [adjusted odds ratio (aOR) = 1.4, 95% confidence interval (CI) = 1.0, 1.9] and male sex (aOR = 2.1, 95% CI = 1.5, 2.9) were associated with failure. Hazardous alcohol use in the year prior to enrollment was more common in men (57%) than women (24%), P < 0.001. There was no difference in alcohol use effect on failure between sexes (P for interaction > 0.5). Controlling for hazardous alcohol use did not change the relation between sex and failure.

conclusionAlcohol use among HIV-infected adults in Botswana appears to worsen HIV treatment outcomes. Alcohol use does not appear to have either a mediating or a moderating effect on the relation between gender and HIV treatment outcome failure.

Indexed as

AdultAlcohol DrinkingAnti-HIV AgentsBotswanaCohort StudiesComorbidityFemaleHIV InfectionsHumansMaleProspective StudiesSex FactorsTreatment FailureTreatment OutcomeAnti-HIV AgentsAlcoholantiretroviral therapyBotswanaethanolgenderHIV-1outcomes

Identifiers

PMID27447841
PMCPMC5205535
OpenAlexW2479022257

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.